Page last updated: 2024-10-25
ciglitazone and Edema-Proteinuria-Hypertension Gestosis
ciglitazone has been researched along with Edema-Proteinuria-Hypertension Gestosis in 1 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Meister, S | 1 |
Hahn, L | 1 |
Beyer, S | 1 |
Paul, C | 1 |
Mitter, S | 1 |
Kuhn, C | 1 |
von Schönfeldt, V | 1 |
Corradini, S | 1 |
Sudan, K | 1 |
Schulz, C | 1 |
Kolben, TM | 1 |
Mahner, S | 1 |
Jeschke, U | 1 |
Kolben, T | 1 |
Other Studies
1 other study available for ciglitazone and Edema-Proteinuria-Hypertension Gestosis
Article | Year |
---|---|
Regulation of Epigenetic Modifications in the Placenta during Preeclampsia: PPARγ Influences H3K4me3 and H3K9ac in Extravillous Trophoblast Cells.
Topics: Adult; Benzamides; Case-Control Studies; Epigenesis, Genetic; Female; Histones; Humans; Methylation; | 2021 |